Top 8 Frightful CYTH4 Details

005, 95% CI 1.003 to 1.007), age (OR 1.114, 95% CI 1.106 to 1.122), systolic BP (OR 1.036, 95% CI 1.032 to 1.039), serum TG (OR 1.002, 95% CI 1.001 to 1.002), serum HDL-C (OR 1.005, 95% CI 1.000 to 1.009), serum glucose (OR 1.008, 95% CI 1.007 to 1.010), waist circumference (OR 0.999, 95% CI 0.994 to 1.004) and serum CRP (OR 1.121, 95% CI 1.032 to 1.219). Table?1 Characteristics of study participants with and without MetS Table?2 Univariate comparisons between patients with MetS and non-MetS with and without death Table?3 Binary logistic GS-1101 regression analysis for the predictive factors of all-cause mortality in patients with metabolic syndrome Figure?1 Kaplan�CMeier plot of association of serum lactate dehydrogenase tertiles with mortality in participants with metabolic syndrome. For all-cause mortality in paticipants with MetS (shown in table 4), the unadjusted HRs of mode 1 for each tertiles of increasing serum LDH were 1.205 (95% CI 1.007 to 1.441; p=0.041) for serum LDH of 149�C176?U/L compared with 65�C149?U/L, and 1.572 (95% CI 1.315 to 1.881; pCYTH4 LDH of 149�C176?U/L compared with 65�C149?U/L, and 1.273 (95% CI 1.049 to 1.547; p=0.015) for serum LDH of 176�C668?U/L compared with 65�C149?U/L. Table?4 Cox proportional hazards regression of all-cause mortality for serum LDH in those with and without MetS For cardiovascular mortality in participants with MetS (shown in table 5), the unadjusted HRs of mode 1 for each tertiles of increasing serum LDH were 1.394 (95% CI 1.054 to 1.842; p=0.020) for serum PF 01367338 LDH of 149�C176?U/L compared with 65�C149?U/L, and 1.897 (95% CI 1.440 to 2.499; p